Dr. David Riseberg Named Chief of The Division of Hematology & Oncology at Mercy

Mercy medical oncologist Dr. David Riseberg has been named the new Chief of the Division of Hematology and Oncology at Mercy, effective January 1, 2015. Dr. Riseberg replaces Dr. Jack Feldman, Chief of the Division since 1975, who is stepping down as he decreases his clinical activity. 

A graduate of University of Pennsylvania and University of Maryland, Dr. Riseberg completed his clinical training at University and at the National Cancer Institute. He is active in clinical research, and will serve as the Medical Advisor to the Center for Prevention and Research.  Dr. Riseberg will also assume the role of Chair of the Cancer Committee.

A top rated oncologist who is Board Certified in Internal Medicine, Medical Oncology and Hematology, Dr. Riseberg is a highly regarded specialist treating patients with many types of cancers and blood disorders including breast cancer, colon and rectal cancer, gynecologic cancers, lung cancer, leukemia and lymphoma.

Dr. Riseberg has dedicated much of his medical career on the research and treatment of breast cancer and works closely with the surgeons, certified nurse practitioners and nurses in The Hoffberger Breast Center at Mercy.

“Dr. Riseberg came to Mercy under the auspices of Dr. Feldman in 1995 and together, they have cared for thousands of patients. They recruited Mercy physicians Dr. Peter Ledakis and Dr. Sandy Kotiah, as well as Dr. John Downs and Dr. Richard L. Huslig at Hematology and Oncology at Lutherville Personal Physicians. Mercy’s Division of Hematology and Oncology is recognized for its clinical and academic strengths, and will continue its proud tradition under Dr. Riseberg’s leadership,” said Thomas R. Mullen, President and CEO, Mercy Health Services, Mercy Medical Center.